urea has been researched along with amoxicillin in 117 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 26 (22.22) | 18.2507 |
2000's | 38 (32.48) | 29.6817 |
2010's | 49 (41.88) | 24.3611 |
2020's | 4 (3.42) | 2.80 |
Authors | Studies |
---|---|
Ax, F; Bonham, NM; Hallberg, A; Karlén, A; Lennernäs, H; Winiwarter, S | 1 |
Danelian, E; Hämäläinen, MD; Hansson, A; Karlén, A; Karlsson, R; Lennernäs, H; Löfâs, S; Winiwarter, S | 1 |
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Avdeef, A; Tam, KY | 1 |
Castro, Lde P; Chausson, Y; Coelho, LG; Passos, MC | 1 |
Itoh, H; Nakata, H; Nishioka, S | 1 |
Bujanover, Y; Gilat, T; Hallak, A; Konikoff, FM; Moshkowitz, M; Peled, Y; Santo, M; Tiomny, E | 1 |
Goerz, G; Humfeld, S; Reinauer, H; Reinauer, S; Ruzicka, T; Susanto, F | 1 |
Adamek, RJ; Freitag, M; Opferkuch, W; Rühl, GH; Wegener, M | 1 |
Ardill, JE; Dorrian, CA; el-Omar, E; McColl, KE; Penman, I | 1 |
Adamek, RJ; Freitag, M; Labenz, J; Opferkuch, W; Rühl, GH; Wegener, M | 1 |
Larsson, H; Sjöström, JE | 1 |
Estrada, R; Garcia, F; Laine, L; Stein, C; Trujillo, M | 1 |
Braun, M; Idström, JP; Londong, W; Pommerien, W; Wrangstadh, M | 1 |
Braden, B; Lembcke, B; Londong, W; Pommerien, W; Schultze, V; Wrangstadh, M | 1 |
Geypens, B; Ghoos, Y; Hiele, M; Maes, B; Perri, F; Rutgeerts, P | 1 |
Bermejo, F; Boixeda, D; Gisbert, JP; Jiménez, I; Martín de Argila, C; Pérez, T | 1 |
Emami, S; Estrada, R; Laine, L; Trujillo, M | 1 |
Daly, LE; Drumm, B; Durnin, M; Gormally, S; Hetherington, C; Lambert, I; Rowland, M; Thomas, JE | 1 |
Hills, J; McVey, M; Pope, AJ; Richardson, S; Rushant, B; Toseland, CD | 1 |
Färkkilä, M; Haapiainen, R; Kokkola, A; Kosunen, TU; Puolakkainen, P; Rautelin, H; Sipponen, P | 1 |
Andriulli, A; Clemente, R; Conoscitore, P; Festa, V; Ghoos, Y; Niro, G; Perri, F; Quitadamo, M; Rutgeerts, P | 1 |
Higashi, Y; Kashima, K; Kodama, T; Sasaki, Y; Sawai, N; Tanahashi, T; Tatsumi, Y; Yamaoka, Y | 1 |
Cornetta, AM; Gleed, RD; McDonough, PL; Simpson, KW; Strauss-Ayali, D | 1 |
Hibi, T; Ishii, H; Kitahora, T; Mori, M; Nagahashi, S; Suzuki, H; Suzuki, M | 1 |
Cutler, A; Vakil, N | 1 |
Howden, CW; Sharma, VK; Vasudeva, R | 1 |
Bayerdörffer, E; Burman, CF; Díete, U; Dité, P; Domján, L; Kisfalvi, I; Lonovics, J; Mégraud, F; Pap, A; Sipponen, P; Zeijlon, L | 1 |
Asaka, M; Ishizuka, J; Kagaya, H; Katagiri, M; Kato, M; Komatsu, Y; Kudo, M; Kudo, T; Nishikawa, K; Sugiyama, T; Sukegawa, M; Takeda, H; Toyota, J | 1 |
Armuzzi, A; Cammarota, G; Cannizzaro, O; Cianci, R; Gasbarrini, A; Gasbarrini, G; Gentiloni, N; Ojetti, V; Pastorelli, A; Pirozzi, G | 1 |
Carpio, RE; Fock, KM; Ho, J; Hu, FL; Hu, PJ; Huang, NX; Kachintorn, U; Kullavanijaya, P; Lam, SK; Lesmana, L; Li, YY; Manan, C; Perez, JY; Phornphutkul, K; Qian, SC; Wong, BC; Xiao, SD | 1 |
Daudén, E; García-Díez, A; Jiménez-Alonso, I | 1 |
Apfalter, P; Barousch, W; Binder, C; Hirschl, AM; Kuderna, C; Makristathis, A; Pasching, E; Rotter, ML | 1 |
Andriulli, A; Annese, V; Niro, GA; Perri, F; Quitadamo, M; Villani, MR | 1 |
Andriulli, A; Festa, V; Perri, F; Quitadamo, M; Villani, MR | 1 |
Calvet, X; Gené, E; Gisbert, JP; López, T | 1 |
Ashorn, M; Mäkipernaa, A; Ruuska, T | 1 |
Adachi, K; Fujishiro, H; Hashimoto, T; Hattori, S; Hirakawa, K; Ishihara, S; Ishimura, N; Kaji, T; Kawamura, A; Kinoshita, Y; Niigaki, M; Sato, H; Watanabe, M | 1 |
Amini, M; Kamalian, N; Kaviani, MJ; Malekzadeh, R; Massarrat, S; Sotoudeh, M; Vahedi, H | 1 |
Fujisawa, T; Ida, S; Kato, S; Konno, M; Kozaiwa, K; Sawada, A; Tajiri, H; Yoshimura, N | 1 |
Ahmad, MM; Arefin, MS; Bardhan, P; Bauerfeind, P; Beglinger, C; Glatz-Krieger, K; Gyr, N; Hasan, M; Hildebrand, P; Khan, AK; Parvin, S; Rahman, A; Rossi, L; Terracciano, L | 1 |
Barthélemy, P; Caekaert, A; Fléjou, JF; Laurent, J; Mégraud, F | 1 |
Chi, CH; Huang, CC; Kao, AW; Sheu, BS; Wang, YL; Yang, HB | 1 |
Ahn, DS; Choi, IJ; Choi, KW; Chung, IS; Chung, JM; Hong, WS; Jung, HC; Kim, JH; Lee, SI; Rew, JS; Rhee, JC; Yang, US | 1 |
Dhir, V; Laine, L | 1 |
Colin, R | 1 |
Fukai, Y; Fukuchi, M; Katoh, H; Kuwano, H; Manda, R; Masuda, N; Miyazaki, T; Nakajima, M; Ojima, H; Tsukada, K; Tsukada, O | 1 |
Borda, F; Domínguez-Muñoz, JE; Ducons, J; Gallego, S; Gisbert, JP; Gomollón, F; Hervás, A; Iglesias, J; Jiménez, I; Miño, G; Pajares, JM; Pastor, G; Santolaria, S; Vázquez, MA | 1 |
Angeletti, S; De Francesco, V; Hassan, C; Ierardi, E; Lorenzetti, R; Marignani, M; Morini, S; Zullo, A | 1 |
Bästlein, E; Bayerdörffer, E; Haferland, C; Jacobs, E; Kirsch, C; Lehn, N; Miehlke, S; Neumeyer, M; Papke, J; Schneider-Brachert, W; Stolte, M; Vieth, M | 1 |
Barkun, A; Chiba, N; Cockeram, A; Dallaire, C; Fallone, C; Farley, A; Nicholls, B; Simms, L; Veldhuyzen van Zanten, S | 1 |
Andriulli, A; Barberani, F; Festa, V; Merla, A; Perri, F; Pilotto, A | 1 |
Ahuja, V; Bal, CS; Chaudhary, A; Das, B; Pandey, RM; Sharma, MP | 1 |
Doherty, GM; Farrell, S; McCallion, WA; Milliken, I; Murphy, JL; Wootton, SA | 1 |
Cucchiara, S; de'Angelis, GL; Ferzetti, A; Franco, MT; Kuvidi, M; Lerro, P; Marinello, D; Oderda, G; Pensabene, L; Romano, C; Strisciuglio, P | 1 |
Nakagawa, S; Suzuki, K; Taneike, I; Yamamoto, T | 1 |
Barros, H; David, L; Lunet, N; Mendes, N; Serpa, J | 1 |
Chen, CB; Chou, JW; Hsu, CH; Lai, HC; Liao, KF; Lin, ZY; Wang, HH | 1 |
Amadori, S; Newland, AC; Provan, D; Rossi, Z; Stasi, R; Stipa, E | 1 |
Ishiki, K; Mizuno, M; Nagahara, Y; Oguma, K; Okada, H; Shiratori, Y; Take, S; Yokota, K; Yoshida, T | 1 |
Almela, P; Barrio, J; Benito, LM; Bermejo, F; Bory, F; Calvet, X; Carneros, JA; Castro-Fernández, M; Cosme, A; Fernández-Bermejo, M; Franco, A; García-Durán, F; Gisbert, JP; Khorrami, S; Lamas, E; Modolell, I; Niño, P; O'Callaghan, E; Ortiz, V; Ortuño, J; Pérez-Aisa, A; Ponce, J; Rodrigo, L; Sánchez-Pobre, P; Tomas, A; Valer, MP | 1 |
Hibi, T; Iwasaki, E; Masaoka, T; Nishizawa, T; Suzuki, H | 1 |
Bronstein, JA | 1 |
Hassan, C; Ricci, C; Vaira, D; Vakil, N; Zullo, A | 1 |
Dehghani, SM; Erjaee, A; Haghighat, M; Imanieh, MH | 1 |
Amitrano, M; Grossi, L; Manzoli, L; Marzio, L; Sacco, F; Spezzaferro, M | 1 |
Hwang, JH; Jeong, SH; Jung, HC; Kim, JJ; Kim, JW; Kim, N; Kwon, JH; Lee, DH; Lee, JW; Lee, SH; Park, YS; Song, BJ; Song, IS | 1 |
Abbas, Z; Abid, S; Jafri, W; Khalid, A; Khan, R; Naz, S; Yakoob, J | 1 |
Goh, KL; Manikam, J; Qua, CS | 2 |
Chan, AK; Chan, FK; Chau, TS; Lee, KK; Lee, VW; Ling, TK; Waye, MM | 1 |
Boyanova, L; Cabrita, AM; de Carvalho, JN; Gonçalves, TM; Medeiros, JA; Pereira, AM; Pereira, MI | 1 |
Albrecht, P; Kotowska, M; Szajewska, H | 1 |
Buonavolontà, R; Miele, E; Russo, D; Staiano, A; Vecchione, R | 1 |
Anderson, GL; Baker, LH; Bravo, LE; Chey, WD; Correa, P; Crowley, JJ; Dominguez, RL; Ferreccio, C; Goodman, GE; Greenberg, ER; Herrero, R; Lazcano-Ponce, EC; Martínez, ME; Meza-Montenegro, MM; Morgan, DR; Peña, EM; Peña, R; Salazar-Martínez, E; Torres, J; Valdivieso, M | 1 |
de Vrese, M; Kristen, H; Laue, C; Rautenberg, P; Schrezenmeir, J | 1 |
Berning, M; Jebens, C; Knoth, H; Krasz, S; Kuhlisch, E; Laass, MW; Lehn, N; Madisch, A; Miehlke, S; Morgner, A; Neumeyer, M; Schneider-Brachert, W; Stolte, M; Vieth, M; Zekorn, C | 1 |
Funakoshi, R; Kawai, N; Kobayashi, K; Ueno, F; Yamada, Y; Yokoyama, H | 1 |
Aresti-Zárate, S; Ayestarán, B; Campos, MR; Carrascosa, MF; Cobo, M; Cuadrado-Lavín, A; Dierssen-Sotos, T; Fernández-Pousa, A; González-Colominas, E; Hernández, M; Pascual, EL; Salcines-Caviedes, JR | 1 |
Harada, N; Hibi, T; Katayama, S; Katsushima, S; Kawamura, N; Kawanishi, M; Kuwai, T; Maekawa, T; Masuda, E; Nishizawa, T; Nishizawa, Y; Noguchi, K; Ohara, M; Suzuki, H; Suzuki, T; Takahashi, M; Tanaka, M; Toyokawa, T; Tsuruta, H; Yoshio, T | 1 |
Chung, JW; Hahm, KB; Jeong, JY; Jung, YK; Kim, JH; Kim, YJ; Kwon, KA; Lee, JJ; Lee, SM; Yun, SC | 1 |
Georgopoulos, S; Karatapanis, S; Laoudi, F; Lisgos, P; Papantoniou, N; Papastergiou, V; Spiliadi, C; Xirouchakis, E | 1 |
Chiu, KW; Chiu, YC; Chou, YP; Chuah, SK; Hsu, PI; Hu, ML; Hu, TH; Kuo, CM; Kuo, YH; Liang, CM; Tai, WC; Wu, DC; Wu, KL | 1 |
Choi, C; Hwang, JH; Jang, ES; Jeong, SH; Jo, HJ; Jung, HC; Kim, JW; Kim, N; Lee, DH; Lee, SH; Lee, ST; Lim, JH; Park, YS; Shin, CM; Song, Is | 1 |
Alaoui, S; Amarti, A; Benajah, DA; Bennani, B; El Abkari, M; El Rhazi, K; Ibrahimi, SA; Lahbabi, M; Mahmoud, M; Nejjari, C | 1 |
Almasi, S; Mirsattari, D; Seyedmajidi, S; Seyyedmajidi, M; Zali, M; Zanganeh, E; Zojaji, H | 1 |
Barrio, J; Bory, F; Calvet, X; Castro, M; de la Coba, C; Ducons, J; Forné, M; Gisbert, JP; Marin, AC; McNicholl, AG; Molina-Infante, J; Montoro, M; Perez-Aisa, A | 1 |
Bonfrate, L; Castorani, L; D'Ambrosio, P; De Francesco, V; Hassan, C; Portincasa, P; Ruggiero, V; Scaccianoce, G; Vannella, L; Zullo, A | 1 |
Benzer, E; Bilir, G; Gokcan, H; Onal, IK; Oztas, E | 1 |
Furuta, T; Ichikawa, H; Osawa, S; Sahara, S; Sugimoto, K; Sugimoto, M; Umemura, K; Uotani, T; Watanabe, H; Yamada, T; Yamade, M | 1 |
Attumi, TA; Graham, DY | 1 |
Ekere, F; Emanuel, AO; Igetei, R; Odiagah, JN; Onyekwere, CA; Smith, S | 1 |
Harada, N; Hosoda, Y; Inoue, S; Katayama, S; Kimura, T; Kuwai, T; Maekawa, T; Masuda, E; Miyabayashi, H; Nishizawa, T; Nishizawa, Y; Ohta, H; Saito, H; Suzuki, H; Takahashi, M; Toyokawa, T; Watanabe, N; Yamashita, H; Yoshinaga, M; Yoshio, T | 1 |
Cho, Y; Chung, KH; Hwang, JH; Jeong, SH; Jin, E; Kim, JW; Kim, N; Lee, DH; Seo, JY; Shin, CM | 1 |
Delgado, M; Eizaguirre, FJ; Fernández-Reyes, M; Montes, M; Muñoz-Seca, IM; Pérez-Trallero, E; Villalon, FN | 1 |
Almela, P; Angueira, T; Ariño, I; Barrio, J; Bermejo, F; Domínguez, JL; Domínguez-Muñoz, JE; Federico, A; Fernández, N; Fernandez-Bermejo, M; Ferrer-Barcelo, L; Gisbert, JP; Gomez, B; Gomez-Camarero, J; Gravina, AG; Lucendo, AJ; Marín, AC; Martin-Noguerol, E; Martorano, M; McNicholl, AG; Medina, E; Millastre, J; Miranda, A; Modolell, I; Molina-Infante, J; Ortuño, J; Perez-Aisa, Á; Perona, M; Rodríguez-Tellez, M; Romano, M | 1 |
Hong, SN; Kim, JJ; Lee, H; Lee, JH; Lee, YC; Min, BH; Rhee, PL | 1 |
Algaba, A; Angueira, T; Barrio, J; Bermejo, F; Castro-Fernández, M; Del Castillo, F; Domínguez, JL; Federico, A; Fernández-Salazar, L; Gisbert, JP; Gómez, B; Gómez, J; Gravina, AG; Herranz, M; Lucendo, AJ; Marín, AC; Martorano, M; McNicholl, AG; Miranda, A; Modolell, I; Molina-Infante, J; Ortuño, J; Pabón, M; Romano, M; Solís-Muñoz, P; Velayos, B | 1 |
Akkan, T; Aktaş, B; Atbaşı, ST; Başyiğit, S; Nazlıgül, Y; Şimşek, G; Uzman, M; Yılmaz, B; Yüksel, O | 1 |
Annibale, B; Calabrese, C; Caselli, M; Di Mario, F; Farinati, F; Gasbarrini, G; Gullini, S; Ierardi, E; Luzza, F; Maconi, G; Ojetti, V; Pretolani, S; Romano, M; Rugge, M; Savio, A; Stockbrugger, R; Zagari, RM | 1 |
Brennan, DE; Breslin, N; Haider, RB; Hall, B; Holleran, G; McNamara, D; O'Connor, HJ; O'Morain, C; Omorogbe, J; Smith, SM | 1 |
Huan, ML; Jia, YY; Jing, ZW; Kang, TB; Luo, M; Wan, N; Zhang, BL; Zhou, SY | 1 |
Durukan, E; Erhamamci, S; Gokturk, HS; Ozgur, GT; Unler, GK | 1 |
An, HJ; Chen, Y; Cheng, H; Cui, M; Dong, L; Gao, H; Gao, W; Gong, J; Hu, F; Jiang, B; Jiang, K; Li, J; Li, Y; Liang, H; Meng, F; Sheng, J; Wang, B; Wang, H; Wei, H; Yang, L; Yang, Y; Zhang, G; Zhang, S; Zhao, P; Zhao, Y; Zuo, X | 1 |
Georgopoulos, SD; Grivas, E; Kasapidis, P; Laoudi, F; Martinez-Gonzales, B; Mentis, A; Michopoulos, S; Petraki, K; Sgouras, D; Sotiropoulou, M; Spiliadi, C; Xirouchakis, E; Zampeli, E; Zografos, K | 1 |
Fujita, M; Graham, DY; Haruma, K; Ishii, M; Kamada, T; Katsumata, R; Matsumoto, H; Murao, T; Nakato, R; Shiotani, A | 1 |
Bair, MJ; Chang, CC; Chang, CY; Chen, CC; Chen, CY; Chen, MJ; Chen, PY; Chen, YN; El-Omar, EM; Fang, YJ; Hsu, WF; Hsu, YC; Hu, WH; Lee, JY; Lee, YC; Lin, JT; Liou, JM; Luo, JC; Sheu, BS; Shun, CT; Tseng, CH; Wu, JY; Wu, MS; Yang, TH | 1 |
Al-Deyab, SS; El-Hamshary, H; Fang, J; Mo, X; Wang, J; Wu, Y; Yang, X; Yu, K; Zhou, X; Zhu, T | 1 |
Ding, Y; Fu, W; Song, Z; Suo, B; Tian, X; Wang, L; Xue, Y; Zhou, L | 1 |
Jia, YY; Jing, ZW; Li, C; Luo, M; Mei, QB; Zhang, BL; Zhou, SY | 2 |
Chen, DF; Fan, L; Lan, CH; Wang, TY; Wang, XW; Yang, J; Zhang, Y; Zhu, YJ | 1 |
Cogdill, AG; Guevara, B | 1 |
Ding, YM; Duan, M; Han, ZX; Ji, R; Kong, QZ; Li, YQ; Li, YY; Lin, BS; Lin, MJ; Liu, J; Wan, M; Wang, J; Wang, ST; Zhang, WL; Zuo, XL | 1 |
Abraham, P; Desai, D; Dhoble, P; Doctor, S; Gupta, T; Joshi, A | 1 |
Patel, J; Singh, AK; Singh, J; Singh, KR | 1 |
2 review(s) available for urea and amoxicillin
Article | Year |
---|---|
Helicobacter pylori and idiopathic chronic urticaria.
Topics: Adult; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Carbon Isotopes; Case-Control Studies; Chronic Disease; Clarithromycin; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prevalence; Turkey; Urea; Urticaria | 2000 |
Helicobacter pylori: A Review of Current Diagnostic and Management Strategies.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens, Bacterial; Biopsy; Bismuth; Breath Tests; Clarithromycin; Culture Techniques; Doxycycline; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Feces; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Nitro Compounds; Organometallic Compounds; Peptic Ulcer; Polymerase Chain Reaction; Proton Pump Inhibitors; Rifabutin; Salicylates; Salvage Therapy; Serologic Tests; Stomach Neoplasms; Tetracycline; Thiazoles; Treatment Outcome; Urea | 2020 |
68 trial(s) available for urea and amoxicillin
Article | Year |
---|---|
Efficacy of lansoprazole and amoxicillin in eradicating Helicobacter pylori: evaluation using 13C-UBT and Monoclonal H. pylori antibody testing.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Antibodies, Bacterial; Antibodies, Monoclonal; Breath Tests; Drug Therapy, Combination; Duodenal Ulcer; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Monitoring, Physiologic; Omeprazole; Penicillins; Pepsinogens; Stomach Ulcer; Urea | 1995 |
Intravenous omeprazole/amoxicillin and omeprazole pretreatment in Helicobacter pylori-positive acute peptide ulcer bleeding. A pilot study.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Aged, 80 and over; Amoxicillin; Breath Tests; Carbon Radioisotopes; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Injections, Intravenous; Male; Middle Aged; Omeprazole; Peptic Ulcer Hemorrhage; Pilot Projects; Prospective Studies; Stomach Ulcer; Time Factors; Urea; Urease | 1994 |
Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer.
Topics: Amoxicillin; Anti-Bacterial Agents; Basal Metabolism; Breath Tests; Carbon Radioisotopes; Duodenal Ulcer; Female; Gastric Acid; Gastrin-Releasing Peptide; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Infusions, Intravenous; Male; Metronidazole; Organometallic Compounds; Pepsin A; Peptides; Time Factors; Urea | 1993 |
Medium-term results of oral and intravenous omeprazole/amoxicillin Helicobacter pylori eradication therapy.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Amoxicillin; Breath Tests; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Injections, Intravenous; Male; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Stomach Ulcer; Urea | 1994 |
Prospective evaluation of the macrolide antibiotic dirithromycin for the treatment of Helicobacter pylori.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Drug Combinations; Erythromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Macrolides; Male; Metronidazole; Middle Aged; Omeprazole; Pilot Projects; Prospective Studies; Urea | 1996 |
Pharmacokinetic and pharmacodynamic interactions between omeprazole and amoxycillin in Helicobacter pylori-positive healthy subjects.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Area Under Curve; Breath Tests; Cross-Over Studies; Double-Blind Method; Drug Interactions; Gastric Acidity Determination; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Urea | 1996 |
Dose-response of omeprazole combined with amoxycillin on duodenal ulcer healing and eradication of Helicobacter pylori.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Urea | 1996 |
Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Bismuth; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Combinations; Female; Follow-Up Studies; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine; Salicylates; Tetracycline; Urea | 1997 |
Carbon 13-labeled urea breath test for the diagnosis of Helicobacter pylori infection in children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Biopsy; Breath Tests; Carbon Radioisotopes; Child; Child, Preschool; Fasting; Female; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Male; Metronidazole; Organometallic Compounds; Predictive Value of Tests; Sensitivity and Specificity; Urea | 1997 |
Positive result by serology indicates active Helicobacter pylori infection in patients with atrophic gastritis.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Antibodies, Bacterial; Breath Tests; Drug Therapy, Combination; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Male; Urea | 1998 |
Relationship between the results of pre-treatment urea breath test and efficacy of eradication of Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Tinidazole; Treatment Outcome; Urea | 1998 |
Ten-day triple therapy with ranitidine bismuth citrate, amoxicillin, and clarithromycin in eradicating Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Penicillins; Ranitidine; Urea | 1999 |
Efficacy of two different dosage regimens of omeprazole, amoxycillin and metronidazole for the cure of Helicobacter pylori infection.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Breath Tests; Drug Resistance; Drug Therapy, Combination; Endoscopy; Europe; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Pyloric Antrum; Pylorus; Time Factors; Urea | 1999 |
Eradication of Helicobacter pylori using 30 mg or 60 mg lansoprazole combined with amoxicillin and metronidazole: one and two weeks of a new triple therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Carbon Isotopes; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Time Factors; Treatment Outcome; Urea | 1999 |
Five-day regimens containing ranitidine bismuth citrate plus high-dose clarithromycin and either amoxycillin or tinidazole for Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Penicillins; Prospective Studies; Ranitidine; Tinidazole; Urea | 2000 |
Comparison of lansoprazole-based triple and dual therapy for treatment of Helicobacter pylori-related duodenal ulcer: an Asian multicentre double-blind randomized placebo controlled study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Asia; Breath Tests; Clarithromycin; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Risk Factors; Urea | 2000 |
Ranitidine bismuth citrate-based triple therapies after failure of the standard 'Maastricht triple therapy': a promising alternative to the quadruple therapy?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Benzimidazoles; Bismuth; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Proton Pump Inhibitors; Ranitidine; Recurrence; Sulfoxides; Tinidazole; Treatment Outcome; Urea | 2001 |
Predictors of failure of Helicobacter pylori eradication with the standard 'Maastricht triple therapy'.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Age Factors; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Biopsy; Breath Tests; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Endoscopy; Helicobacter Infections; Humans; Omeprazole; Pantoprazole; Penicillins; Prospective Studies; Proton Pump Inhibitors; Risk Factors; Smoking; Sulfoxides; Urea | 2001 |
Helicobacter pylori and iron deficiency anaemia in children.
Topics: Adolescent; Amoxicillin; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Child; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Hemoglobins; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Proton Pump Inhibitors; Urea | 2001 |
Efficacy of ecabet sodium for Helicobacter pylori eradication triple therapy in comparison with a lansoprazole-based regimen.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abietanes; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Carbon Isotopes; Clarithromycin; Diterpenes; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Pepsin A; Prospective Studies; Treatment Outcome; Urea; Urease | 2001 |
Various durations of a standard regimen (amoxycillin, metronidazole, colloidal bismuth sub-citrate for 2 weeks or with additional ranitidine for 1 or 2 weeks) on eradication of Helicobacter pylori in Iranian peptic ulcer patients. A randomized controlled
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Biopsy, Needle; Bismuth; Breath Tests; Drug Administration Schedule; Drug Therapy, Combination; Esophagoscopy; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Ranitidine; Urea | 2001 |
A randomized comparison of four omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia.
Topics: Administration, Oral; Adult; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Breath Tests; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Penicillins; Treatment Outcome; Urea | 2001 |
Impact of intravenous omeprazole on Helicobacter pylori eradication by triple therapy in patients with peptic ulcer bleeding.
Topics: Administration, Oral; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Endoscopy; Female; Helicobacter Infections; Helicobacter pylori; Hemorrhage; Humans; Infusions, Intravenous; Male; Middle Aged; Penicillins; Peptic Ulcer; Ranitidine; Recurrence; Treatment Outcome; Urea | 2002 |
Efficacy of low-dose clarithromycin triple therapy and tinidazole-containing triple therapy for Helicobacter pylori eradication.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Breath Tests; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Tinidazole; Treatment Outcome; Urea | 2002 |
Helicobacter pylori eradication does not worsen quality of life related to reflux symptoms: a prospective trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Gastroesophageal Reflux; Helicobacter Infections; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Quality of Life; Urea | 2002 |
Duodenal ulcer healing with 1-week eradication triple therapy followed, or not, by anti-secretory treatment: a multicentre double-blind placebo-controlled trial.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Placebos; Proton Pump Inhibitors; Treatment Outcome; Urea | 2002 |
Seven-day triple therapy with omeprazole, amoxycillin and clarithromycin for Helicobacter pylori infection in haemodialysis patients.
Topics: Age Factors; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Kidney Diseases; Male; Middle Aged; Omeprazole; Renal Dialysis; Retreatment; Sex Factors; Time Factors; Treatment Outcome; Urea | 2002 |
Validation of the 13c-urea breath test for the initial diagnosis of helicobacter pylori infection and to confirm eradication after treatment.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Carbon Isotopes; Clarithromycin; Confidence Intervals; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Likelihood Functions; Male; Middle Aged; Omeprazole; Penicillins; ROC Curve; Sensitivity and Specificity; Time Factors; Urea | 2003 |
A prospective, randomized study of quadruple therapy and high-dose dual therapy for treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Tetracycline; Urea | 2003 |
A randomized trial comparing seven-day ranitidine bismuth citrate and clarithromycin dual therapy to seven-day omeprazole, clarithromycin and amoxicillin triple therapy for the eradication of Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Satisfaction; Ranitidine; Time Factors; Urea | 2003 |
Randomized study of different 'second-line' therapies for Helicobacter pylori infection after failure of the standard 'Maastricht triple therapy'.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Breath Tests; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Pantoprazole; Prospective Studies; Ranitidine; Sulfoxides; Tinidazole; Treatment Failure; Urea | 2003 |
Rank order of success favors longer duration of imidazole-based therapy for Helicobacter pylori in duodenal ulcer disease: a randomized pilot study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Imidazoles; Lansoprazole; Male; Middle Aged; Omeprazole; Pilot Projects; Prospective Studies; Time Factors; Tinidazole; Urea | 2004 |
Total family unit Helicobacter pylori eradication and pediatric re-infection rates.
Topics: Adolescent; Amoxicillin; Breath Tests; Child; Child, Preschool; Clarithromycin; Community-Acquired Infections; Family Health; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Recurrence; Urea | 2004 |
Dual vs. triple therapy for childhood Helicobacter pylori gastritis: a double-blind randomized multicentre trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Amoxicillin; Breath Tests; Child; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Omeprazole; Recurrence; Tinidazole; Urea | 2004 |
Lewis and Secretor status and Helicobacter pylori eradication.
Topics: Amoxicillin; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Phenotype; Tinidazole; Treatment Outcome; Urea | 2004 |
One-year follow-up study of Helicobacter pylori eradication rate with 13C-urea breath test after 3-d and 7-d rabeprazole-based triple therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Carbon Isotopes; Clarithromycin; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Rabeprazole; Treatment Outcome; Urea | 2005 |
Second-line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 patients.
Topics: Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Treatment Failure; Urea | 2008 |
Efficacy of the standard quadruple therapy versus triple therapies containing proton pump inhibitor plus amoxicillin and clarithromycin or amoxicillin-clavulanic acid and metronidazole for Helicobacter pylori eradication in children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Child; Child, Preschool; Clarithromycin; Clavulanic Acid; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Metronidazole; Omeprazole; Organometallic Compounds; Proton Pump Inhibitors; Single-Blind Method; Treatment Outcome; Urea | 2009 |
Efficacy of four different moxifloxacin-based triple therapies for first-line H. pylori treatment.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aza Compounds; Breath Tests; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Moxifloxacin; Quinolines; Urea; Young Adult | 2010 |
Pharmacogenetics of esomeprazole or rabeprazole-based triple therapy in Helicobacter pylori eradication in Hong Kong non-ulcer dyspepsia Chinese subjects.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Asian People; Breath Tests; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance, Bacterial; Dyspepsia; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Hong Kong; Humans; Male; Middle Aged; Mutation; Pharmacogenetics; Polymorphism, Genetic; Prospective Studies; Rabeprazole; Urea | 2010 |
Evaluation of Helicobacter pylori eradication by triple therapy plus Lactobacillus acidophilus compared to triple therapy alone.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Combined Modality Therapy; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lactobacillus acidophilus; Male; Microbial Sensitivity Tests; Middle Aged; Peptic Ulcer; Probiotics; Single-Blind Method; Treatment Outcome; Urea; Young Adult | 2011 |
Sequential therapy compared with standard triple therapy for Helicobacter pylori eradication in children: a double-blind, randomized, controlled trial.
Topics: Adult; Amoxicillin; Anti-Infective Agents; Breath Tests; Carbon Isotopes; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Male; Omeprazole; Proton Pump Inhibitors; Tinidazole; Urea | 2011 |
Helicobacter pylori chronic gastritis in children: to eradicate or not to eradicate?
Topics: Adolescent; Aluminum Hydroxide; Amoxicillin; Antacids; Anti-Bacterial Agents; Breath Tests; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Gastritis; Helicobacter Infections; Humans; Magnesium Hydroxide; Male; Metronidazole; Omeprazole; Proton Pump Inhibitors; Severity of Illness Index; Urea | 2011 |
14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Latin America; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Time Factors; Treatment Outcome; Urea | 2011 |
Probiotic lactobacilli and bifidobacteria in a fermented milk product with added fruit preparation reduce antibiotic associated diarrhea and Helicobacter pylori activity.
Topics: Adult; Amoxicillin; Bifidobacterium; Breath Tests; Clarithromycin; Cultured Milk Products; Diarrhea; Double-Blind Method; Female; Fruit; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Lactobacillus acidophilus; Male; Middle Aged; Probiotics; Urea | 2011 |
Randomized trial on 14 versus 7 days of esomeprazole, moxifloxacin, and amoxicillin for second-line or rescue treatment of Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aza Compounds; Breath Tests; Drug Therapy, Combination; Esomeprazole; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Quinolines; Salvage Therapy; Time Factors; Treatment Outcome; Urea; White People | 2011 |
Levofloxacin versus clarithromycin in a 10 day triple therapy regimen for first-line Helicobacter pylori eradication: a single-blind randomized clinical trial.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Proton Pump Inhibitors; Single-Blind Method; Spain; Time Factors; Treatment Outcome; Urea; Young Adult | 2012 |
Ten-day sequential versus triple therapy for Helicobacter pylori eradication: a prospective, open-label, randomized trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Chi-Square Distribution; Clarithromycin; Confidence Intervals; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Lansoprazole; Male; Metronidazole; Middle Aged; Patient Compliance; Republic of Korea; Urea | 2012 |
Nonbismuth quadruple "concomitant" therapy versus standard triple therapy, both of the duration of 10 days, for first-line H. pylori eradication: a randomized trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Medication Adherence; Metronidazole; Middle Aged; Prospective Studies; Treatment Outcome; Urea | 2013 |
The efficacy of second-line anti-Helicobacter pylori therapy using an extended 14-day levofloxacin/amoxicillin/proton-pump inhibitor treatment--a pilot study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pilot Projects; Proton Pump Inhibitors; Taiwan; Time Factors; Treatment Outcome; Urea | 2012 |
Clinical outcomes of two-week sequential and concomitant therapies for Helicobacter pylori eradication: a randomized pilot study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pilot Projects; Proton Pump Inhibitors; Rabeprazole; Treatment Outcome; Urea | 2013 |
Penbactam for Helicobacter pylori eradication: a randomised comparison of quadruple and triple treatment schedules in an Iranian population.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Ampicillin; Analysis of Variance; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Combinations; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Proton Pump Inhibitors; Sulbactam; Urea; Young Adult | 2013 |
Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Disease Eradication; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Treatment Outcome; Urea; Young Adult | 2014 |
Concomitant, sequential, and hybrid therapy for H. pylori eradication: a pilot study.
Topics: Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Omeprazole; Pilot Projects; Proton Pump Inhibitors; Tinidazole; Urea | 2013 |
Effect of dosing schemes of amoxicillin on eradication rates of Helicobacter pylori with amoxicillin-based triple therapy.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastric Juice; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Treatment Outcome; Urea; Young Adult | 2014 |
High-dose extended-release lansoprazole (dexlansoprazole) and amoxicillin dual therapy for Helicobacter pylori infections.
Topics: Amoxicillin; Anti-Bacterial Agents; Breath Tests; Dexlansoprazole; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Pilot Projects; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome; Urea | 2014 |
Rabeprazole, clarithromycin, and amoxicillin Helicobacter pylori eradication therapy: report of an efficacy study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Rabeprazole; Time Factors; Treatment Outcome; Urea; Young Adult | 2014 |
Clarithromycin Versus Metronidazole as First-line Helicobacter pylori Eradication: A Multicenter, Prospective, Randomized Controlled Study in Japan.
Topics: Aged; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Metronidazole; Middle Aged; Prospective Studies; Rabeprazole; Urea | 2015 |
Comparison of efficacy and safety of levofloxacin-containing versus standard sequential therapy in eradication of Helicobacter pylori infection in Korea.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Rabeprazole; Republic of Korea; Treatment Outcome; Urea | 2015 |
Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments.
Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Antidiarrheals; Bismuth; Breath Tests; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Humans; Levofloxacin; Male; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Urea | 2015 |
The impact of amalgam dental fillings on the frequency of Helicobacter pylori infection and H. pylori eradication rates in patients treated with concomitant, quadruple, and levofloxacin-based therapies.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Dental Amalgam; Dental Restoration, Permanent; Disease Eradication; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Levofloxacin; Male; Metronidazole; Middle Aged; Outpatients; Prospective Studies; Rabeprazole; Tetracycline; Treatment Outcome; Turkey; Urea | 2015 |
A randomized-controlled study to compare the efficacy of sequential therapy with standard triple therapy for Helicobacter pylori eradication in an Irish population.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Ireland; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome; Urea; Young Adult | 2015 |
[Quadruple regimens using domestically manufactured drugs in gastritis and duodenal ulcer patients for Helicobacter pylori eradication: a perspective, multicenter, randomized controlled trial].
Topics: Amoxicillin; Antacids; Bismuth; Breath Tests; Drug Therapy, Combination; Duodenal Ulcer; Gastritis; Gastroesophageal Reflux; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Prospective Studies; Proton Pump Inhibitors; Urea | 2016 |
Randomized clinical trial comparing ten day concomitant and sequential therapies for Helicobacter pylori eradication in a high clarithromycin resistance area.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Biopsy; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Proton Pump Inhibitors; Pyloric Antrum; Urea | 2016 |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Organometallic Compounds; Proton Pump Inhibitors; Taiwan; Tetracycline; Urea | 2016 |
Randomized Clinical Trial: Esomeprazole, Bismuth, Levofloxacin, and Amoxicillin or Cefuroxime as First-Line Eradication Regimens for Helicobacter pylori Infection.
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Breath Tests; Cefuroxime; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Levofloxacin; Male; Medication Adherence; Microbial Sensitivity Tests; Middle Aged; Proton Pump Inhibitors; Treatment Failure; Urea | 2017 |
Eradication Efficacy of Modified Dual Therapy Compared with Bismuth-Containing Quadruple Therapy as a First-Line Treatment of Helicobacter pylori.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Costs; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Medication Adherence; Middle Aged; Organometallic Compounds; Treatment Outcome; Urea | 2019 |
Ten-day concomitant and sequential therapy for Helicobacter pylori effective in region with high antibiotic resistance rates.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Treatment Outcome; Urea | 2022 |
47 other study(ies) available for urea and amoxicillin
Article | Year |
---|---|
Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach.
Topics: Humans; Intestinal Absorption; Jejunum; Models, Biological; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship | 1998 |
SPR biosensor studies of the direct interaction between 27 drugs and a liposome surface: correlation with fraction absorbed in humans.
Topics: Humans; Intestinal Absorption; Liposomes; Pharmaceutical Preparations; Pharmacokinetics; Predictive Value of Tests; Surface Plasmon Resonance | 2000 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Five-day bismuth-free triple therapy for the eradication of Helicobacter pylori and reduction of duodenal ulcer relapse.
Topics: Adult; Amoxicillin; Breath Tests; Carbon Radioisotopes; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Duodenoscopy; Female; Follow-Up Studies; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Recurrence; Urea | 1991 |
High Helicobacter pylori numbers are associated with low eradication rate after triple therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Chronic Disease; Colony Count, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Organometallic Compounds; Urea; Urease | 1995 |
Helicobacter pylori in patients with systemic sclerosis: detection with the 13C-urea breath test and eradication.
Topics: Adult; Aged; Amoxicillin; Breath Tests; Carbon Isotopes; Drug Therapy, Combination; Dyspepsia; Esophagitis, Peptic; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Risk Factors; Scleroderma, Systemic; Stomach Diseases; Urea | 1994 |
Factors affecting growth and antibiotic susceptibility of Helicobacter pylori: effect of pH and urea on the survival of a wild-type strain and a urease-deficient mutant.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzamides; Clarithromycin; Drug Interactions; Duodenal Ulcer; Enzyme Inhibitors; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Metronidazole; Microbial Sensitivity Tests; Mutation; Omeprazole; Penicillins; Urea; Urease | 1996 |
The influence of isolated doses of drugs, feeding and colonic bacterial ureolysis on urea breath test results.
Topics: Adult; Amoxicillin; Bacteria; Bismuth; Breath Tests; Colon; Drug Therapy, Combination; Eating; False Negative Reactions; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Sucralfate; Urea | 1995 |
[Is there a correlation between the values of breath tests and the response to the treatment for the eradication of Helicobacter pylori?].
Topics: Amoxicillin; Anti-Ulcer Agents; Breath Tests; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Retrospective Studies; Urea | 1996 |
Effect of potent urease inhibitor, fluorofamide, on Helicobacter sp. in vivo and in vitro.
Topics: Amoxicillin; Animals; Benzamides; Breath Tests; Drug Stability; Drug Therapy, Combination; Enzyme Inhibitors; Female; Ferrets; Helicobacter Infections; Helicobacter pylori; Hydrogen-Ion Concentration; Male; Penicillins; Urea; Urease | 1998 |
Analysis of the 13C-urea breath test for detection of Helicobacter pylori infection based on the kinetics of delta-13CO2 using laser spectroscopy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Predictive Value of Tests; Proton Pump Inhibitors; Sensitivity and Specificity; Spectrum Analysis; Urea | 1998 |
Use of a [13C]urea breath test for detection of gastric infection with Helicobacter spp in dogs.
Topics: Amoxicillin; Animals; Anti-Infective Agents; Anti-Ulcer Agents; Biopsy; Breath Tests; Carbon Isotopes; Dog Diseases; Dogs; Famotidine; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Male; Metronidazole; Reproducibility of Results; Specific Pathogen-Free Organisms; Stomach; Urea; Urease | 1998 |
Gastric urease activity is inversely associated with the success of treatment for Helicobacter pylori: effect of sofalcone.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Breath Tests; Carbon Isotopes; Chalcone; Chalcones; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Proton Pump Inhibitors; Stomach Ulcer; Treatment Outcome; Urea; Urease | 1998 |
A survey of gastroenterologists' perceptions and practices related to Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Attitude of Health Personnel; Breath Tests; Carbon Isotopes; Carbon Radioisotopes; Clarithromycin; Drug Resistance, Microbial; Enzyme Inhibitors; Gastroenterology; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Penicillins; Practice Patterns, Physicians'; Proton Pump Inhibitors; Radiopharmaceuticals; Surveys and Questionnaires; Urea | 1999 |
Two enzyme immunoassays and PCR for detection of Helicobacter pylori in stool specimens from pediatric patients before and after eradication therapy.
Topics: Adolescent; Amoxicillin; Antibodies, Bacterial; Breath Tests; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Feces; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Immunoenzyme Techniques; Immunoglobulin G; Omeprazole; Polymerase Chain Reaction; Time Factors; Urea | 2000 |
What is the optimal length of proton pump inhibitor-based triple therapies for H. pylori? A cost-effectiveness analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Carbon Isotopes; Clarithromycin; Cost-Benefit Analysis; Decision Support Techniques; Drug Administration Schedule; Drug Costs; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Penicillins; Proton Pump Inhibitors; Proton Pumps; Treatment Outcome; Urea | 2001 |
A 13C-urea breath test in children with helicobacter pylori infection: assessment of eradication therapy and follow-up after treatment.
Topics: Adolescent; Amoxicillin; Biopsy; Breath Tests; Carbon Radioisotopes; Child; Child, Preschool; Drug Therapy, Combination; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Male; Penicillins; Proton Pumps; Urea | 2001 |
Recrudescence and reinfection with Helicobacter pylori after eradication therapy in Bangladeshi adults.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Bangladesh; Body Mass Index; Breath Tests; Carbon Isotopes; Developing Countries; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Organometallic Compounds; Patient Compliance; Peptic Ulcer; Ranitidine; Recurrence; Tinidazole; Urea | 2001 |
A third-line levofloxacin-based rescue therapy for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Glossitis; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Omeprazole; Penicillins; Prospective Studies; Rabeprazole; Treatment Outcome; Urea | 2003 |
Intrafamilial spread of the same clarithromycin-resistant Helicobacter pylori infection confirmed by molecular analysis.
Topics: Adult; Amoxicillin; Breath Tests; Child; Clarithromycin; Disease Transmission, Infectious; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Urea | 2004 |
Helicobacter pylori eradication in the management of patients with idiopathic thrombocytopenic purpura.
Topics: Amoxicillin; Breath Tests; Clarithromycin; Dyspepsia; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Male; Middle Aged; Omeprazole; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Treatment Outcome; Urea | 2005 |
The effect of eradicating helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Duodenal Ulcer; Female; Follow-Up Studies; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Proton Pump Inhibitors; Risk Factors; Stomach Neoplasms; Stomach Ulcer; Urea | 2005 |
A new eradication resistance index as a predictor of metronidazole-containing second-line treatment of Helicobacter pylori.
Topics: Aged; Amoxicillin; Anti-Infective Agents; Breath Tests; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Predictive Value of Tests; Severity of Illness Index; Treatment Failure; Urea | 2007 |
[National ranking exam. N63. What could fall at the exam?].
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Education, Medical; Educational Measurement; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Proton Pump Inhibitors; Time Factors; Treatment Outcome; Urea | 2008 |
Duplicate breath testing to confirm eradication of Helicobacter pylori: incremental benefit and cost in 419 patients.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Carbon Isotopes; Clarithromycin; Cost-Benefit Analysis; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastroscopy; Health Care Costs; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Stomach Ulcer; Urea; Young Adult | 2008 |
Ten-day sequential therapy as first-line treatment for Helicobacter pylori infection in Korea: a retrospective study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Korea; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Time Factors; Treatment Outcome; Urea | 2010 |
Risk factors associated with Helicobacter pylori infection treatment failure in a high prevalence area.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Bacterial Proteins; Breath Tests; Clarithromycin; Drug Resistance, Bacterial; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Pakistan; Point Mutation; Prevalence; Risk Factors; RNA, Bacterial; RNA, Ribosomal, 23S; Treatment Failure; Urea; Virulence Factors; Young Adult | 2011 |
Efficacy of 1-week proton pump inhibitor triple therapy as first-line Helicobacter pylori eradication regime in Asian patients: is it still effective 10 years on?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Malaysia; Male; Middle Aged; Pantoprazole; Proton Pump Inhibitors; Retrospective Studies; Treatment Outcome; Urea; Young Adult | 2010 |
High-dose rabeprazole-amoxicillin dual therapy and rabeprazole triple therapy with amoxicillin and levofloxacin for 2 weeks as first and second line rescue therapies for Helicobacter pylori treatment failures.
Topics: Amoxicillin; Anti-Bacterial Agents; Breath Tests; Drug Therapy, Combination; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Treatment Failure; Treatment Outcome; Urea | 2012 |
[Effect of pharmaceutical care in the diagnosis of Helicobacter pylori infection using 13C-urea breath test].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; False Negative Reactions; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Pharmaceutical Services; Pharmacists; Proton Pump Inhibitors; Surveys and Questionnaires; Urea | 2012 |
Dual therapy for third-line Helicobacter pylori eradication and urea breath test prediction.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Predictive Value of Tests; Prospective Studies; Rabeprazole; Sensitivity and Specificity; Urea | 2012 |
Prevalence of Helicobacter pylori and its recurrence after successful eradication in a developing nation (Morocco).
Topics: Adult; Amoxicillin; Anti-Infective Agents; Breath Tests; Carbon Isotopes; Clarithromycin; Developing Countries; Drug Therapy, Combination; Educational Status; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Hospitals, University; Humans; Lost to Follow-Up; Male; Medication Adherence; Metronidazole; Middle Aged; Morocco; Omeprazole; Prevalence; Prospective Studies; Proton Pump Inhibitors; Recurrence; Urea; Urease; Young Adult | 2013 |
What is the impact of Helicobacter pylori density on the success of eradication therapy: a clinico-histopathological study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Breath Tests; Case-Control Studies; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Stomach; Tetracycline; Treatment Outcome; Urea; Young Adult | 2013 |
The efficacy of moxifloxacin-containing triple therapy after standard triple, sequential, or concomitant therapy failure for Helicobacter pylori eradication in Korea.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Cohort Studies; Drug Therapy, Combination; Female; Fluoroquinolones; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Moxifloxacin; Organometallic Compounds; Peptic Ulcer; Rabeprazole; Republic of Korea; Retrospective Studies; Salvage Therapy; Stomach; Tetracycline; Treatment Failure; Treatment Outcome; Urea | 2014 |
Helicobacter pylori Infection in Children. Antimicrobial Resistance and Treatment Response.
Topics: Adolescent; Amoxicillin; Anti-Infective Agents; Breath Tests; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Europe; Female; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Male; Metronidazole; Remission Induction; Retrospective Studies; Treatment Outcome; Urea | 2015 |
Two-week, high-dose proton pump inhibitor, moxifloxacin triple Helicobacter pylori therapy after failure of standard triple or non-bismuth quadruple treatments.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Cohort Studies; Drug Therapy, Combination; Esomeprazole; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Moxifloxacin; Prospective Studies; Proton Pump Inhibitors; Retreatment; Treatment Failure; Treatment Outcome; Urea | 2015 |
Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antigens, Bacterial; Barrett Esophagus; Bismuth; Breath Tests; Clarithromycin; Disease Management; Drug Therapy, Combination; Dyspepsia; Feces; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Italy; Levofloxacin; Metronidazole; Proton Pump Inhibitors; Stomach Neoplasms; Urea | 2015 |
Design and evaluation of novel pH-sensitive ureido-conjugated chitosan/TPP nanoparticles targeted to Helicobacter pylori.
Topics: Amoxicillin; Chitosan; Drug Liberation; Flow Cytometry; HEK293 Cells; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Microscopy, Confocal; Nanoparticles; Polyphosphates; Urea | 2016 |
Does the urea breath test predict eradication of Helicobacter pylori infection?
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Carbon Radioisotopes; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome; Urea | 2016 |
Helicobacter pylori Eradication with Proton Pump Inhibitors or Potassium-Competitive Acid Blockers: The Effect of Clarithromycin Resistance.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Peptic Ulcer; Polymerase Chain Reaction; Proton Pump Inhibitors; Pyrroles; Retrospective Studies; RNA, Ribosomal, 23S; Sulfonamides; Treatment Outcome; Urea | 2016 |
Incorporation of amoxicillin-loaded organic montmorillonite into poly(ester-urethane) urea nanofibers as a functional tissue engineering scaffold.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Bentonite; Cell Line; Cell Proliferation; Delayed-Action Preparations; Drug Delivery Systems; Drug Design; Gelatin; Inflammation; Mice; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Nanofibers; Nanotechnology; Polyesters; Rats; Skin; Stress, Mechanical; Tissue Engineering; Tissue Scaffolds; Urea; Urethane; X-Ray Diffraction | 2017 |
Construction and optimization of pH-sensitive nanoparticle delivery system containing PLGA and UCCs-2 for targeted treatment of Helicobacter pylori.
Topics: Amoxicillin; Animals; Cell Death; Chitosan; Drug Delivery Systems; Drug Liberation; HEK293 Cells; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Lactic Acid; Male; Mice, Inbred BALB C; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Stomach; Urea | 2018 |
Anti-Helicobacterpylori effectiveness and targeted delivery performance of amoxicillin-UCCs-2/TPP nanoparticles based on ureido-modified chitosan derivative.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Biological Transport; Chitosan; Cytokines; Drug Carriers; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Hydrogen-Ion Concentration; Male; Mice; Mice, Inbred BALB C; Nanoparticles; Polyphosphates; Stomach; Structure-Activity Relationship; Urea | 2018 |
Clinical practice of Helicobacter pylori infection management by gastroenterologists in secondary and tertiary hospitals: A stratified sampling cross-sectional survey.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Cross-Sectional Studies; Drug Therapy, Combination; Gastroenterologists; Helicobacter Infections; Helicobacter pylori; Humans; Penicillins; Proton Pump Inhibitors; Tertiary Care Centers; Urea | 2022 |
Multifunctional Cu:ZnS quantum dots for degradation of Amoxicillin and Dye Sulphon Fast Black-F and efficient determination of urea for assessing environmental aspects.
Topics: Amoxicillin; Quantum Dots; Sulfides; Urea; Water; Water Pollutants; Zinc Compounds | 2023 |